(Press-News.org) On Nov. 18, the heart failure and transplantation team at Emory University Hospital (EUH) made history, performing the first-ever surgical implantation in the United States of a brand-new type of ventricular assist device (VAD), which provides crucial care to patients with failing hearts.
An expert team led by veteran cardiothoracic surgeon Mani Daneshmand, MD, successfully implanted a novel magnetically levitated pump, a VAD that has been specifically designed for patient ease and long-term health. The BrioVAD System, made by BrioHealth Solutions Inc., was authorized by the FDA to begin clinical trials earlier this year. Emory became the first site enrolled in the trial to perform the procedure.
As part of the INNOVATE clinical trial, Emory will participate in gathering data on patient experience with the device, joined by other leading medical institutions across the country, including Cleveland Clinic Foundation, Duke University and University of Chicago.
The entry criteria for joining the study were rigorous. Emory qualified because of its high quality and extensive VAD experience. Emory has long led Metro Atlanta and the region in number and success rate of VAD implantations. Since the program began, Emory Healthcare has completed almost 1,000 VAD implants between EUH and Emory St. Joseph's Hospital.
“We’re honored to be the first implanting site in this study,” Daneshmand says. “The BrioVAD is a promising heart assist pump, designed from the ground up with focus on patient safety and quality of life. With this study, we continue our long history of innovation in pursuit of our mission to bring compassionate, quality care to every patient who arrives at our doors seeking care.”
First used in the 1960s, VADs have been an effective treatment for patients with advanced heart failure, often providing an alternative for patients who don’t qualify for a transplant — which can mean the difference between life and death.
The lifesaving device, which has evolved significantly over the decades, works by providing mechanical circulatory support and helping to pump blood from the lower chambers of the heart to the rest of the body. Because the device is almost always placed on the left side of the heart, the device is frequently referred to as an LVAD.
The BrioVAD system is composed of a “hemocompatible blood pump,” meaning that it interacts with the blood in a way that may have fewer side effects. The new VAD also includes a fully magnetically levitated rotor and two small, lightweight, patient-worn components.
“The BrioVAD shows great promise to improve on the current, excellent LVAD technology we are using every day,” says Daneshmand, who is the Andrew J. McKelvey Professor at Emory School of Medicine and Director of Thoracic Transplant and MCS Surgery.
The hope is that the new VAD may be used as life-long destination therapy, meaning that the VAD is used instead of transplant, or as bridge therapy to transplant or even for supporting recovery of the heart. The INNOVATE trial will assess the system performance in both the short term, with a six-month endpoint, and in the long term over the course of the next 24 months.
Note: The BrioVAD System is an Investigational Device limited by Federal Law to use in the INNOVATE Trial.
About the INNOVATE Trial
The INNOVATE Trial is a prospective, non-blinded, randomized, controlled study that will enroll patients for both short-term and long-term Mechanical Circulatory Support indications.
About BrioHealth Solutions
BrioHealth Solutions is a medical device company headquartered in Burlington, Massachusetts. It develops, produces and commercializes devices to treat patients suffering from advanced and persistent heart failure.
END
Emory heart team implants new blood-pumping device for first time in U.S.
The BrioVAD System, made by BrioHealth Solutions Inc., was authorized by the FDA to begin clinical trials earlier this year. Emory became the first site enrolled in the trial to perform the procedure.
2024-11-26
ELSE PRESS RELEASES FROM THIS DATE:
Congenital heart defects caused by problems with placenta
2024-11-26
Congenital heart defects are the most common form of human birth defect, but we still don’t fully understand what causes them. Previous research had suggested that some heart defects could be triggered by problems with the placenta, the organ that provides oxygen and nutrients to the developing embryo. Now, researchers at Nanjing University, China have confirmed this link by focusing on a protein whose levels are reduced in many patients with congenital heart defects, called SLC25A1. SLC25A1 plays a key role in transporting ...
Schlechter named Cancer Moonshot Scholar
2024-11-26
Chelsey Schlechter, MPH, PhD, Huntsman Cancer Institute investigator and assistant professor in the Department of Population Health Sciences at the University of Utah (the U), has been selected as a Cancer Moonshot Scholar.
Schlechter is one of only eleven researchers in the U.S. chosen for the prestigious program this year, which aims to both advance impactful cancer research and broaden the research workforce.
For the project, Schlechter and her team partnered with the Association for Utah Community Health and Utah Community Health Centers—organizations which ...
Two-way water transfers can ensure reliability, save money for urban and agricultural users during drought in Western U.S., new study shows
2024-11-26
A new study led by researchers at the University of North Carolina at Chapel Hill offers a solution to water scarcity during droughts amid the tug of economic development, population growth and climate uncertainty for water users in Western U.S. states. The proposed two-way leasing contracts would coordinate agricultural-to-urban leasing during periods of drought and urban-to-agricultural leasing during wet periods, benefiting both urban and agricultural water users.
“Water markets are an important tool for allocating water in the Western U.S., and other water-scarce regions around the world, but they are often slow to respond to drought, ...
New issue of advances in dental research explores the role of women in dental, clinical, and translational research
2024-11-26
Alexandria, VA, USA - The Journal of Dental Research (JDR) has announced the publication of a new issue of Advances in Dental Research, a supplement to the Journal of Dental Research (JDR), entitled, "Women in Dental, Clinical, and Translational Research.”
The 2024 Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research (AADOCR) and the Canadian Association for Dental Research featured a two-day “Meeting Within a Meeting” on the topic of “Women in Dental, Clinical, and Translational Research” organized by AADOCR Then- President Alexandre Vieira. During these sessions, speakers were challenged to reflect on ...
Team unlocks new insights on pulsar signals
2024-11-26
Team Unlocks New Insights on Pulsar Signals
November 26, 2024, Mountain View, CA – Dr. Sofia Sheikh from the SETI Institute led a study that sheds new light on how pulsar signals—the spinning remnants of massive stars—distort as they travel through space. This study, published in The Astrophysical Journal, was performed by a multi-year cohort of undergraduate researchers in the Penn State branch of the Pulsar Search Collaboratory student club. Maura McLaughlin, Chair, Eberly Distinguished Professor of Physics and Astronomy, West Virginia University, created the Pulsar Search Collaboratory to engage ...
Great apes visually track subject-object relationships like humans do
2024-11-26
Great apes track events with their eyes in the same way that humans do, according to a study published November 26th in the open-access journal PLOS Biology by Vanessa Wilson from the University of Neuchatel, Switzerland, and colleagues.
When watching a cat chase a mouse, humans will alternate looking at cat and mouse, using the information to connect the two into what’s called an agent-patient relationship—with the cat as the agent and the mouse as the patient. This cognitive mechanism is thought to be ...
Recovery of testing for heart disease risk factors post-COVID remains patchy
2024-11-26
Routine screening to detect risk factors for heart disease dropped sharply during the COVID-19 pandemic in England, and some key measurements, such as blood pressure readings, may still lag behind pre-pandemic levels. These findings are reported in a new study by Frederick Ho and Naveed Sattar of the University of Glasgow, Scotland, UK, and colleagues published November 26th in the open-access journal PLOS Medicine.
During the COVID-19 pandemic, patients went without routine face-to-face health checks, which are important for detecting common cardiometabolic ...
Final data and undiscovered images from NASA’s NEOWISE
2024-11-26
While NASA’s NEOWISE telescope ended its journey through space on Nov. 1, 2024, the team at IPAC, a science center at Caltech, was working on one further gift from the prolific mission.
The final data release from NEOWISE was released to the astronomy community just two weeks later, on Nov. 14, encompassing over 26 million images and nearly 200 billion sources detected by the telescope. And today, IPAC is releasing six new images from the mission’s archival data as a tribute to this landmark project, available here: https://www.astropix.org/link/3b2x
NEOWISE ...
Nucleoporin93: A silent protector in vascular health
2024-11-26
"Research in the last several decades has established endothelial cells (ECs) as a dynamic interface critical for vascular protection.”
BUFFALO, NY- November 26, 2024 – This editorial was published by Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) in Volume 16, Issue 17, titled, “The silent protector: Nucleoporin93’s role in vascular health.”
Written by Julia Michalkiewicz, Tung D. Nguyen, and Monica Y. Lee from The University of Illinois at Chicago College of Medicine, ...
Can we avert the looming food crisis of climate change?
2024-11-26
WASHINGTON, Nov. 26, 2024 – Human activities are causing atmospheric carbon dioxide (CO2) levels to rise, which increases the global average surface temperature—and poses a threat to crop growth. Escalating concerns about climate change’s impact on global food security inspired researchers from Banaras Hindu University in India to create a way to explore how these factors influence crop yields.
In Chaos, from AIP Publishing, the researchers share a mathematical model created to capture the nonlinear relationships between CO2, temperature, human population, ...
LAST 30 PRESS RELEASES:
Wrong trees in the wrong place can make cities hotter at night, study reveals
New gene therapy reverses heart failure in large animal model
Young children less likely than adults to see discrimination as harmful
Tiny poops in the ocean may help solve the carbon problem
Study offers insight into chloroplast evolution
Advancing the synthesis of two-dimensional gold monolayers
Human disruption is driving ‘winner’ and ‘loser’ tree species shifts across Brazilian forests
A novel heme-model compound that treats lethal gas poisoning
Shape-changing device helps visually impaired people perform location task as well as sighted people - EMBARGO: Tuesday 10 December (10:00 UK time)
AI predicts that most of the world will see temperatures rise to 3°C much faster than previously expected
Second round of FRONTIERS Science Journalism Residency Program awards grants to ten journalists
The inequity of wildfire rescue resources in California
Aerosol pollutants from cooking may last longer in the atmosphere – new study
Breakthrough in the precision engineering of four-stranded β-sheets
Family income predicts adult problems more than neighborhood poverty
Leading stress expert Ron de Kloet on hormone's dual nature: From protection to harm
Almost half of young vapers are able to stop with quitline help
After a divisive election, most U.S. adults ready to avoid politics this holiday
Food insecurity in LA County remains well above national average, despite slight decline
People with a positive attitude are built differently
AML, sickle cell disease research among highlights of UC ASH abstracts
Dozens of presentations advance multiple myeloma research at the 2024 American Society for Hematology (ASH) meeting
ASH 2024: Study shows that genetic mutations accumulate in smokers with myelodysplastic syndromes and worsen outcomes
Nature inspires self-assembling helical polymer
Could US-style summer holiday programs boost Aussie kids’ health?
Towards safer, higher performance batteries through network topology optimization
ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias
Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment
US e-scooter/e-bike injuries have tripled since 2019, fuelled by alcohol/substance use
Cost stops 1 in 6 US adults with asthma from taking meds as prescribed, study suggests
[Press-News.org] Emory heart team implants new blood-pumping device for first time in U.S.The BrioVAD System, made by BrioHealth Solutions Inc., was authorized by the FDA to begin clinical trials earlier this year. Emory became the first site enrolled in the trial to perform the procedure.